A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/565 (2006.01) A61K 31/57 (2006.01) A61P 15/18 (2006.01)
Patent
CA 2540697
An extended triphasic oral contraceptive regimen is disclosed. According to the disclosed regimen, a combination of an estrogen and a progestin is administered for at least 42 consecutive days followed by a hormone-free period of from 4 to 8 days. The estrogen and progestin are administered in a contraceptively effective daily dosage for a sequence of at least two cycles of at least 21 days, wherein the estrogen dosage remains constant over each cycle and the progestin dosage increases in three phases over each cycle.
L'invention concerne un régime contraceptif oral triphasique étendu. Selon ce régime, une combinaison d'un oestrogène et d'une progestine est administrée pendant au moins 42 jours consécutifs suivis d'une période sans hormones de 4 à 8 jours. L'oestrogène et la progestine sont administrés en dose quotidienne efficace du point de vue contraceptif pour une séquence d'au moins deux cycles d'au moins 21 jours, la dose d'oestrogène restant constante dans chaque cycle et la dose de progestine augmentant en trois phases dans chaque cycle.
Janssen Pharmaceutica N.v.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Extended triphasic contraceptive regimens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extended triphasic contraceptive regimens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extended triphasic contraceptive regimens will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1788328